• Press release
3 min time reading

2025 first quarter sales: Strong start to the year, demonstrating the relevance of our health-oriented portfolio

  • Corporate news
  • Strong Q1 2025, with sales of €6,844m, up +4.3% on a like-for-like (LFL) basis
  • Contributions from both volume/mix (+1.9%) and price (+2.4%); positive volume/mix again in all categories
  • Broad-based growth, demonstrating the resilience of our business
    • Very strong performance in China, North Asia & Oceania, in all categories
    • Solid growth in North America, led by a continued, winning momentum in High Protein 
    • Consistent progress in Europe with solid volume/mix
  • 2025 guidance confirmed, in line with mid-term ambition: LFL sales growth expected between +3% and +5%, with recurring operating income growing faster than sales  

Access to the full Press Release here